Australia's most trusted
source of pharma news
Posted 22 September 2021 AM
New therapies including AstraZeneca's biologic Enhertu and two Bayer drugs are close to being registered in Australia.
The drugs are among seven new therapies yet to be registered here that appeared on the TGA's latest poisons standard yesterday (Tuesday), which comes into effect 1 October, indicating they are not far off.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.